levodopa has been researched along with hydrogen in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Soares-da-Silva, P | 1 |
| Bendsoe, N; Ronquist, G | 1 |
| Hattori, N; Hirayama, M; Nakahara, T; Ohta, S; Takanashi, M; Yoritaka, A | 1 |
| Abe, T; Fukae, J; Hatano, T; Hattori, N; Hirasawa, M; Hirayama, M; Kawajiri, S; Kazama, A; Kihara, T; Machida, Y; Maeda, T; Miwa, H; Ohtsuka, C; Okuma, Y; Oyama, G; Saiki, H; Shimo, Y; Shimura, H; Suzuki, C; Tomiyama, M; Watanabe, H; Yoritaka, A | 1 |
| Gao, X; Li, Z; Liu, J; Ren, W; Sun, Y; Tang, H; Wang, F; Zhang, Y; Zhao, QX | 1 |
| Hattori, N; Hayashi, T; Kobayashi, Y; Saiki, S; Yoritaka, A | 1 |
3 trial(s) available for levodopa and hydrogen
| Article | Year |
|---|---|
Pilot study of Hâ‚‚ therapy in Parkinson's disease: a randomized double-blind placebo-controlled trial.
Topics: Aged; Antiparkinson Agents; Double-Blind Method; Female; Humans; Hydrogen; Japan; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects; Severity of Illness Index; Statistics, Nonparametric; Water | 2013 |
A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics.
Topics: Aged; Antiparkinson Agents; Double-Blind Method; Female; Humans; Hydrogen; Levodopa; Male; Middle Aged; Parkinson Disease; Water | 2016 |
Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson's disease: a pilot study.
Topics: Aged; Animals; Antiparkinson Agents; Double-Blind Method; Humans; Hydrogen; Levodopa; Parkinson Disease; Pilot Projects; Treatment Outcome | 2021 |
3 other study(ies) available for levodopa and hydrogen
| Article | Year |
|---|---|
Renal tubular dopamine outward transfer during Na(+)-H+ exchange activation by alpha 1- and alpha 2-adrenoceptor agonists.
Topics: Adrenergic alpha-Agonists; Amiloride; Animals; Bucladesine; Colforsin; Dopamine; Hydrogen; In Vitro Techniques; Kidney Tubules; Levodopa; Phenylephrine; Phorbol 12,13-Dibutyrate; Quinoxalines; Rats; Sodium; Sphingosine | 1993 |
Inhibition of the L-dopa transport system in human epidermal Langerhans cells by omeprazole and its analogues.
Topics: Adenosine Triphosphatases; Biological Transport, Active; Cells, Cultured; Cytoplasmic Vesicles; Enzyme Inhibitors; Epidermal Cells; Gastric Mucosa; Humans; Hydrogen; Lactic Acid; Langerhans Cells; Levodopa; Omeprazole; Potassium | 2004 |
Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology.
Topics: Administration, Oral; Adult; Antiparkinson Agents; Cellulose; Chemistry, Pharmaceutical; Drug Combinations; Drug Liberation; Excipients; Female; Humans; Hydrazines; Levodopa; Male; Povidone; Starch; Tablets; Taste; Technology, Pharmaceutical; Young Adult | 2020 |